Skip to main content
. 2022 Jan 12;17(1):e0262169. doi: 10.1371/journal.pone.0262169

Fig 4. Seroconversion was associated with prior COVID-19 symptoms.

Fig 4

Seroconversion to anti-spike IgG (green) and anti-nucleocapsid IgG (brown) prior to study inclusion (circles) and during the follow-up period (triangles) was associated with self-reported anosmia, ageusia, fever, muscle or joint pain, presence of any symptoms, malaise, cough, headache, abdominal symptoms, dyspnea, or runny nose. CI: Confidence Interval.